Viatris Inc

VTRS 10-Q · Q3 2025

VTRS Q3 2025 request

Playground key active
Request URL /api/financials?ticker=VTRS&year=2025&quarter=3
waiting 0 ms
Pick an endpoint and run the request.
curl

Income Statement

Income Statement
Metric Q3 2025 Q3 2024 YoY
Revenue 3,747.5 3,738 +0.3%
Show Product Lines breakouts
Amitiza ® 40.8 38.2 +6.8%
Brands 2,436.8 2,362.2 +3.2%
Brands · Developed Markets Segment 1,241.3 1,217.6 +1.9%
Brands · Emerging Markets Segment 424.1 395.9 +7.1%
Brands · Greater China 612.3 559.4 +9.5%
Brands · Japan, Australia and New Zealand Segment 159.1 189.3 -16.0%
Celebrex ® 73.3 74.1 -1.1%
Creon ® 93.1 84.6 +10.0%
Dymista ® 33.8 43.5 -22.3%
Effexor ® 67.2 66.3 +1.4%
EpiPen® Auto-Injectors 157.2 123.2 +27.6%
Generics 1,310.7 1,375.8 -4.7%
Generics · Developed Markets Segment 1,014.3 1,081.1 -6.2%
Generics · Emerging Markets Segment 146.3 137.3 +6.6%
Generics · Greater China 2.9 2.4 +20.8%
Generics · Japan, Australia and New Zealand Segment 147.2 155 -5.0%
Influvac ® 125.4 121.3 +3.4%
Lipitor 396.1 375.6 +5.5%
Lyrica ® 126.5 129.9 -2.6%
Norvasc 179.7 168.9 +6.4%
Viagra ® 105.2 100.2 +5.0%
Xalabrands 38.6 41.2 -6.3%
Xanax ® 34.2 38.6 -11.4%
Yupelri ® 71.4 62.2 +14.8%
Zoloft ® 66.8 60.6 +10.2%
Show Business Segments breakouts
Developed Markets Segment · Operating Segments 2,255.6 2,298.7 -1.9%
Emerging Markets Segment · Operating Segments 570.4 533.2 +7.0%
Greater China · Operating Segments 615.2 561.8 +9.5%
Japan, Australia and New Zealand Segment · Operating Segments 306.3 344.3 -11.0%
Other Revenue 12.4 13.2 -6.1%
Show Product Lines breakouts
Product And Service Other · Developed Markets Segment 10 9.5 +5.3%
Product And Service Other · Emerging Markets Segment 1.4 2.1 -33.3%
Product And Service Other · Japan, Australia and New Zealand Segment 1 1.2 -16.7%
Revenue 3,759.9 3,751.2 +0.2%
Show Business Segments breakouts
Developed Markets Segment 2,265.6 2,308.2 -1.8%
Emerging Markets Segment 571.8 535.3 +6.8%
Greater China 615.2 562.2 +9.4%
Japan, Australia and New Zealand Segment 307.3 345.5 -11.1%
Cost of Revenue 2,388.4 2,292 +4.2%
Gross Profit 1,371.5 1,459.2 -6.0%
Research & Development 250.4 198.4 +26.2%
Show Consolidation Items breakouts
Material Reconciling Items 250.4 198.4 +26.2%
Selling, General & Administrative 886.6 1,003.4 -11.6%
Gain Loss Related To Litigation Settlement 55.7 31.5 +76.8%
Show Consolidation Items breakouts
Material Reconciling Items 55.7 31.5 +76.8%
Operating Expenses 1,192.7 1,233.3 -3.3%
Operating Income 178.8 225.9 -20.8%
Show Business Segments breakouts
Developed Markets Segment · Operating Segments 944.1 1,042.1 -9.4%
Emerging Markets Segment · Operating Segments 233.6 208.2 +12.2%
Greater China · Operating Segments 416.8 362.2 +15.1%
Japan, Australia and New Zealand Segment · Operating Segments 70.2 102.9 -31.8%
Show Consolidation Items breakouts
Operating Segments 1,664.7 1,715.4 -3.0%
Interest Expense 119.6 145.6 -17.9%
Other Non-Operating Income (Expense) 67.1 -10.2 +757.8%
Show Disposal Group Classification breakouts
OTC Business -6.5 -27.5 +76.4%
Income Before Taxes -7.9 90.5 -108.7%
Income Tax Expense (Benefit) 120.3 -4.3 +2897.7%
Net Income Loss Available To Common Stockholders Basic -128.2 94.8 -235.2%
EPS (Basic) -0.11 0.08 -237.5%
EPS (Diluted) -0.11 0.08 -237.5%
Wtd Avg Shares (Basic) 1,164.6 1,193.5 -2.4%
Wtd Avg Shares (Diluted) 1,164.6 1,200.4 -3.0%
Comprehensive Income -177 383.7 -146.1%
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax (Q)
Show Derivative Risk breakouts
Foreign Exchange Contract · Cash Flow Hedging 6.2 -27.5 +122.5%
Foreign Exchange Contract · Net Investment Hedging 1.2 -4.3 +127.9%
Foreign Exchange Contract · Nondesignated 18 -168.4 +110.7%
Interest Rate Swap · Cash Flow Hedging -0.9 -1.2 +25.0%
Interest Rate Swap · Net Investment Hedging 1.9 -21.7 +108.8%

Balance Sheet

Balance Sheet
Metric Q3 2025 Q3 2024 YoY
Current Assets
Cash & Cash Equivalents 975.3 1,878.7 -48.1%
Accounts Receivable 3,371.6 3,717.4 -9.3%
Show Accounts Notes Loans And Financing Receivable By Receivable Type breakouts
Variable Consideration 2,492.5 2,596.3 -4.0%
Inventory 4,111.4 4,084.6 +0.7%
Prepaid Expenses & Other Current Assets 1,493.1
Total Current Assets 9,951.4 11,307.7 -12.0%
Non-Current Assets
Property, Plant & Equipment 2,626.2 2,676.9 -1.9%
Goodwill 6,730.8
Show Business Segments breakouts
Developed Markets Segment 5,004.7
Emerging Markets Segment 797.1
Greater China 929
Deferred Tax Assets 999 763.1 +30.9%
Other Non-Current Assets 1,890.1 2,465.8 -23.3%
Total Assets 37,920.4 44,754.1 -15.3%
Operating Lease Right-of-Use Assets 265.9 267.6 -0.6%
Intangible Assets 14,945.1 17,087.3 -12.5%
Other Assets
Intangible Assets Net Excluding Goodwill 15,722.9 17,978.9 -12.5%
Current Liabilities
Accounts Payable Trade Current 1,793.4 1,925.9 -6.9%
Current Portion of Long-Term Debt 1,951.9 1,446.7 +34.9%
Other Liabilities Current 3,618.8 3,855.7 -6.1%
Total Current Liabilities 7,364.1 7,512.4 -2.0%
Debt Current 1,944.3
Show Debt Instrument breakouts
Other Current Portion of Long-term Debt 0.9
YEN Term Loan 270.4
Non-Current Liabilities
Long-Term Debt 12,487.6 14,303.4 -12.7%
Show Debt Instrument breakouts
2028 Euro Senior Notes · Senior Notes 877.4 831.8 +5.5%
2028 Senior Notes [Member] · Senior Notes 749.4 749.2 0.0%
2043 Senior Notes (5.400% coupon) · Senior Notes 497.6 497.5 0.0%
2046 Senior Notes (5.250% coupon) · Senior Notes 999.9 999.9 0.0%
2048 Senior Notes [Member] · Senior Notes 747.9 747.9 0.0%
Other Long Term Debt [Member] 2.4 3 -20.0%
Deferred Tax Liabilities 1,028.2 1,276.6 -19.5%
Other Non-Current Liabilities 1,822.9 1,869.3 -2.5%
Total Liabilities 22,702.8 24,961.7 -9.0%
Long-Term Debt (Q)
Show Debt Instrument breakouts
2027 Euro Senior Notes · Net Investment Hedging 850
2027 Euro Senior Notes · Senior Notes 1,012.7
2027 Senior Notes · Senior Notes 760
2028 Euro Senior Notes · Net Investment Hedging 750
2030 Senior Notes · Senior Notes 1,490.8
2032 Euro Senior Notes · Net Investment Hedging 1,250
2032 Euro Senior Notes · Senior Notes 1,550.6
2040 Senior Notes · Senior Notes 1,631.9
2050 Senior Notes · Senior Notes 2,188
YEN Term Loan · Net Investment Hedging 40,000
Show Derivative Instruments Gain Loss By Hedging Relationship breakouts
Net Investment Hedging 2,850
Operating Lease Liabilities 171.4 188.1 -8.9%
Stockholders' Equity
Common Stock 12.5 12.3 +1.6%
Additional Paid-In Capital 18,890.7 18,888.7 0.0%
Retained Earnings -48.2
Accumulated Other Comprehensive Income -2,713.2
Stockholders Equity Parent Before Treasury Stock 16,141.8 20,296.7 -20.5%
Treasury Stock Value 924.2 504.3 +83.3%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 15,217.6 19,792.4 -23.1%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -2,713.2 -2,686.3 -1.0%
Additional Paid In Capital 18,890.7 18,888.7 0.0%
Common Stock 12.5 12.3 +1.6%
Retained Earnings -48.2 4,082 -101.2%
Total Liabilities & Equity 37,920.4 44,754.1 -15.3%
Total Stockholders' Equity (Q)
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment 250.4 262.5 -4.6%
Accumulated Gain Loss Net Cash Flow Hedge Parent -4.2 -8.1 +48.1%
Accumulated Net Unrealized Investment Gain Loss -0.4 -0.6 +33.3%
Accumulated Other Comprehensive Income -2,713.2 -2,686.3 -1.0%
Accumulated Translation Adjustment -3,059 -3,168.9 +3.5%
Aoci Derivative Qualifying As Hedge Excluded Component Parent 100 228.8 -56.3%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q3 2025 YTD Q3 2024 YoY
Operating Activities
Depreciation & Amortization 2,031.5 2,147 -5.4%
Stock-Based Compensation 128.3 113.8 +12.7%
Deferred Income Taxes -228.3 -518.7 +56.0%
Gain Loss On Sale Of Business 79.1 295.8 -73.3%
Show Disposal Group Classification breakouts
Disposal Group Held For Sale Or Disposed Of By Sale Not Discontinued Operations · Other Nonoperating Income Expense 79.1
Payments To Acquire In Process Research And Development Other 15 -12.7 +218.1%
Other Non-Cash Items 835.8 -180.6 +562.8%
Changeinnoncashlitigationsettlementsnet -45.1 245.6 -118.4%
Change in Accounts Receivable 62.7 -0.4 +15775.0%
Change in Inventory -122.2 -687.8 +82.2%
Increase Decrease In Accounts Payable Trade -186.5 -9.7 -1822.7%
Increase Decrease In Accrued Income Taxes Payable -238.4 286.9 -183.1%
Increase Decrease In Other Operating Capital Net -593.8 -62.3 -853.1%
Net Cash from Operations 1,500.1 1,820.2 -17.6%
Investing Activities
Capital Expenditures -182.3 -185.6 +1.8%
Payments To Acquire Marketable Securities -18.1 -21.7 +16.6%
Proceeds From Sale And Maturity Of Marketable Securities 18.1 21.7 -16.6%
Other Investing Activities -32.9 -20.1 -63.7%
Proceeds From Refund Of In Process Research And Development -15 12.7 -218.1%
Proceeds From Sale Of Productive Assets 13.7 2.2 +522.7%
Net Cash from Investing -216.5 1,969.4 -111.0%
Financing Activities
Share Repurchases 415.4 250 +66.2%
Proceeds From Repayments Of Short Term Debt 1.7 1.5 +13.3%
Tax Withholding for Share Compensation -30.3 -53.3 +43.2%
Payments Of Merger Related Costs Financing Activities -13.1 -31.5 +58.4%
Payments Of Financing Costs -1.3 -4.8 +72.9%
Payments To Minority Shareholders -423 -431.5 +2.0%
Proceeds From Issuance Of Common Stock 2 1.9 +5.3%
Proceeds From Payments For Other Financing Activities -178.1 196.9 -190.5%
Net Cash from Financing -1,057.5 -2,910.2 +63.7%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 41.3 7.1 +481.7%
Net Change in Cash 267.4 886.5 -69.8%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1,003.5 1,880.1 -46.6%

Values in millions USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key